Bristol-Myers Squibb
Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
BMY Key Statistics
Stock Snapshot
As of today, Bristol-Myers Squibb(BMY) shares are valued at $62.29. The company's market cap stands at 127.01B, with a P/E ratio of 13.99 and a dividend yield of 3.99%.
As of 2026-11-07, Bristol-Myers Squibb(BMY) stock has fluctuated between $61.33 and $63.06. The current price stands at $62.29, placing the stock +1.6% above today's low and -1.2% off the high.
The Bristol-Myers Squibb(BMY)'s current trading volume is 9.8M, compared to an average daily volume of 10.46M.
During the past year, Bristol-Myers Squibb(BMY) stock moved between $45.27 at its lowest and $68.64 at its peak.
During the past year, Bristol-Myers Squibb(BMY) stock moved between $45.27 at its lowest and $68.64 at its peak.
BMY News
has delivered a 41.4% gain over the past three years, helped by fresh product launches and steady news flow, so the obvious question for you is whether that sha...
Bristol says long-term Camzyos data buoys treatment in children Nov 06, 2026, 5:22 PM ET Bristol-Myers Squibb Company (BMY) Stock By : Jonathan Block, SA News E...
Investing Bristol Myers Squibb Yields Over 4%. Can Its Dividend Survive 2027? A blockbuster blood thinner is about to lose $1.5 billion to $2 billion in sales,...
Analyst ratings
58%
of 31 ratingsMore BMY News
Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers Squibb’s completed study, titled “Real-Wo...
Bristol Myers Squibb (BMY Quick QuoteBMY - Free Report) shares gained 3% following the company's third-quarter earnings release, closing at $62.48 on Oct....
Bristol-Myers Squibb reported Q3 2026 revenue of US$13,069 million and net income of US$2,162 million, alongside encouraging data from late stage oncology and n...
Bristol-Myers Squibb (BMY) just lifted its 2026 guidance after reporting 7% revenue growth in the latest quarter, tying that outlook upgrade to momentum in key...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.